| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business - Strategy Off
1 company
Lin Patrick is a Chief Business - Strategy Off at Processa Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $19K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2021 | PCSA Processa Pharmaceuticals, Inc. | Chief Business - Strategy Off | Buy | 2,000 | $6.65 | $13,300.00 | +0.5% | +4.7% | -59.5% | |
| Oct 1, 2020 | PCSA Processa Pharmaceuticals, Inc. | Chief Business - Strategy Off | Buy | 31,250 | $2.10 | $65,625.00 | +8.5% | - | - |